Sustained release hgf hydrogel preparations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040253294A1
SERIAL NO

10484023

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a sustained release HGF gelatin hydrogel preparation containing a gelatin hydrogel obtained by crosslinking a gelatin having the following properties: (1) an acidic gelatin obtained from collagen by an alkali hydrolysis treatment, (2) a molecular weight of about 100,000-about 200,000 daltons under non-reducing conditions of SDS-PAGE, (3) an isoelectric point of about 5, and (4) a zeta potential in an aqueous solution of about -15 to about -20 mV, and a hepatocyte growth factor (HGF), and an angiogenesis and vasculogenesis promoter and a therapeutic agent for arterial diseases, which contain this preparation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDGEL CORPORATION668-3 MOTOZAIMOKU-CHO FUSHIMI-KU KYOTO-SHI KYOTO 612-8043

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Tabata, Yasuhiko Kyoto-shi, JP 78 277

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation